Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (190)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
18
2024
163
7.480
Why?
Schools, Pharmacy
8
2024
59
3.260
Why?
Pharmacy
3
2023
55
1.900
Why?
Writing
4
2024
46
1.610
Why?
Students, Pharmacy
5
2024
134
1.530
Why?
Faculty
7
2024
71
1.150
Why?
Professional-Patient Relations
3
2019
46
1.140
Why?
Teaching
4
2024
111
1.000
Why?
Educational Measurement
6
2019
202
0.910
Why?
Career Choice
1
2024
116
0.790
Why?
Pharmaceutical Services
2
2023
54
0.780
Why?
Students
3
2024
249
0.770
Why?
Learning
2
2024
156
0.750
Why?
Fellowships and Scholarships
2
2020
124
0.730
Why?
Humans
43
2024
53246
0.720
Why?
Pharmacies
1
2023
62
0.710
Why?
Biomedical Research
1
2024
267
0.680
Why?
Patient-Centered Care
2
2019
141
0.620
Why?
Motivational Interviewing
2
2019
34
0.610
Why?
Health Knowledge, Attitudes, Practice
4
2018
523
0.590
Why?
Blood Pressure
3
2012
518
0.540
Why?
Program Development
2
2018
165
0.540
Why?
Probucol
2
2009
4
0.530
Why?
Mass Screening
2
2011
362
0.520
Why?
Patient Education as Topic
2
2011
325
0.520
Why?
Achievement
1
2017
38
0.510
Why?
Perception
1
2017
124
0.490
Why?
Cross-Sectional Studies
7
2020
1723
0.470
Why?
Feedback
1
2016
53
0.460
Why?
Tetrazoles
2
2008
41
0.460
Why?
Antihypertensive Agents
2
2009
130
0.460
Why?
Hypertension
3
2009
554
0.440
Why?
Health Personnel
1
2017
259
0.420
Why?
Research Personnel
2
2024
73
0.390
Why?
Curriculum
5
2019
409
0.370
Why?
Community Health Services
2
2011
102
0.360
Why?
Energy Drinks
1
2012
6
0.360
Why?
Female
17
2024
28792
0.350
Why?
Caffeine
1
2012
64
0.340
Why?
Faculty, Medical
2
2023
92
0.340
Why?
Platelet Aggregation Inhibitors
2
2012
213
0.330
Why?
Coronary Disease
1
2011
144
0.320
Why?
Universities
2
2024
186
0.320
Why?
Cardiovascular Diseases
3
2012
501
0.310
Why?
Male
15
2024
27444
0.310
Why?
Adrenergic beta-Antagonists
1
2009
108
0.290
Why?
Cardiovascular System
1
2009
55
0.280
Why?
Biphenyl Compounds
1
2008
31
0.280
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
44
0.270
Why?
Benzimidazoles
1
2008
50
0.270
Why?
Thiazolidinediones
1
2007
81
0.250
Why?
Adult
11
2024
14541
0.240
Why?
Coronary Restenosis
1
2005
39
0.230
Why?
Hypoglycemic Agents
1
2007
227
0.220
Why?
Clinical Trials as Topic
4
2009
466
0.210
Why?
Program Evaluation
2
2024
359
0.210
Why?
Smoking
2
2018
526
0.200
Why?
Policy
1
2023
29
0.200
Why?
Career Mobility
1
2023
29
0.200
Why?
Organizational Policy
1
2023
39
0.200
Why?
Academies and Institutes
1
2023
18
0.190
Why?
Communication
2
2022
263
0.190
Why?
Angiotensin Receptor Antagonists
1
2003
22
0.190
Why?
Checklist
1
2023
40
0.190
Why?
Imidazoles
1
2003
114
0.180
Why?
Schools
1
2023
185
0.170
Why?
Angiotensin II
1
2003
161
0.170
Why?
Heart Failure
1
2007
531
0.170
Why?
Itraconazole
3
2008
37
0.170
Why?
Amiodarone
1
2000
23
0.160
Why?
Qualitative Research
1
2023
384
0.160
Why?
Diabetes Mellitus, Type 2
1
2007
591
0.160
Why?
Cannabis
1
2023
155
0.160
Why?
Heart Arrest
2
2007
144
0.160
Why?
Anti-Arrhythmia Agents
1
2000
79
0.160
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
34
0.160
Why?
Mentors
1
2020
57
0.160
Why?
Self Report
1
2020
225
0.140
Why?
Peer Review
1
2018
10
0.140
Why?
Self-Assessment
2
2016
43
0.140
Why?
Pilot Projects
3
2009
727
0.140
Why?
Motivation
1
2020
287
0.130
Why?
Publishing
1
2018
41
0.130
Why?
Risk Factors
4
2011
4018
0.130
Why?
Knowledge
1
2017
28
0.130
Why?
Citrus paradisi
2
2008
10
0.120
Why?
Food-Drug Interactions
2
2008
14
0.120
Why?
Education, Pharmacy, Graduate
1
2016
21
0.120
Why?
Tobacco Products
1
2018
142
0.120
Why?
Pharmacists
3
2023
155
0.110
Why?
Arkansas
3
2023
2068
0.110
Why?
Middle Aged
7
2023
13422
0.100
Why?
Antifungal Agents
2
2008
350
0.100
Why?
Young Adult
3
2018
4514
0.100
Why?
Retrospective Studies
2
2024
6821
0.100
Why?
United States
2
2021
5413
0.090
Why?
Dose-Response Relationship, Drug
2
2008
1367
0.090
Why?
Ticlopidine
1
2012
71
0.090
Why?
Proton Pump Inhibitors
1
2012
95
0.090
Why?
Life Style
1
2011
150
0.080
Why?
Drug Interactions
3
2012
196
0.080
Why?
Atenolol
1
2009
13
0.080
Why?
Health Behavior
1
2011
261
0.080
Why?
Cerebrovascular Disorders
1
2009
51
0.070
Why?
Drug Tolerance
1
2009
60
0.070
Why?
Drug Evaluation, Preclinical
1
2009
142
0.070
Why?
Beverages
2
2008
58
0.070
Why?
Problem-Based Learning
1
2008
51
0.070
Why?
Education, Medical, Undergraduate
1
2008
85
0.060
Why?
Hirudins
1
2007
23
0.060
Why?
Edema
1
2007
64
0.060
Why?
Anaphylaxis
1
2007
69
0.060
Why?
Students, Medical
1
2008
157
0.060
Why?
Drugs, Investigational
1
2005
14
0.060
Why?
Weight Gain
1
2007
245
0.060
Why?
Insulin Resistance
1
2007
282
0.060
Why?
Molecular Structure
1
2005
320
0.050
Why?
Insulin
1
2007
493
0.050
Why?
Risk Assessment
1
2009
1368
0.050
Why?
beta-Cyclodextrins
1
2004
15
0.050
Why?
Tachycardia, Ventricular
2
2003
44
0.050
Why?
Anticoagulants
1
2007
280
0.050
Why?
Antioxidants
1
2005
264
0.050
Why?
Ephedra
1
2003
8
0.050
Why?
Electrocardiography, Ambulatory
1
2003
22
0.050
Why?
Phytotherapy
1
2003
45
0.050
Why?
Plant Preparations
1
2003
41
0.050
Why?
Receptors, Angiotensin
1
2003
11
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
55
0.050
Why?
Adolescent
2
2018
6912
0.050
Why?
Animals
2
2009
13528
0.050
Why?
Practice Guidelines as Topic
2
2007
502
0.050
Why?
Hepatocytes
1
2003
188
0.040
Why?
Interleukin-6
1
2003
272
0.040
Why?
Aged, 80 and over
1
2009
3495
0.040
Why?
Ventricular Fibrillation
1
2000
19
0.040
Why?
Attitude of Health Personnel
1
2023
371
0.040
Why?
Dietary Supplements
1
2003
479
0.040
Why?
Attitude
1
2019
72
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
136
0.040
Why?
Aged
2
2012
10430
0.040
Why?
Liver
1
2003
1150
0.030
Why?
Risk
1
2018
306
0.030
Why?
Pregnant Women
1
2018
71
0.030
Why?
Nicotine
1
2018
180
0.030
Why?
Attitude to Health
1
2018
193
0.030
Why?
Pandemics
1
2021
595
0.030
Why?
Societies, Pharmaceutical
1
2016
15
0.030
Why?
Pharmaceutical Solutions
2
2008
9
0.030
Why?
Accreditation
1
2016
63
0.030
Why?
Child
1
2008
7384
0.030
Why?
Area Under Curve
2
2008
185
0.030
Why?
Cross-Over Studies
2
2008
241
0.030
Why?
Time Factors
2
2012
2992
0.020
Why?
Regression Analysis
1
2012
391
0.020
Why?
Proportional Hazards Models
1
2012
445
0.020
Why?
Acute Coronary Syndrome
1
2012
107
0.020
Why?
Pregnancy
1
2018
2610
0.020
Why?
Cohort Studies
1
2012
1557
0.020
Why?
Peer Group
1
2008
63
0.020
Why?
Hospitalization
1
2012
749
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.020
Why?
Injections, Intravenous
1
2007
129
0.020
Why?
Risk Management
1
2007
31
0.020
Why?
Follow-Up Studies
1
2012
2318
0.020
Why?
Antibodies
1
2007
147
0.020
Why?
Administration, Oral
1
2008
456
0.020
Why?
Renal Insufficiency
1
2007
108
0.020
Why?
Respiratory Insufficiency
1
2007
119
0.010
Why?
Recombinant Proteins
1
2007
489
0.010
Why?
Sex Factors
1
2008
747
0.010
Why?
Clinical Competence
1
2008
406
0.010
Why?
Cyclodextrins
1
2004
16
0.010
Why?
Biological Availability
1
2004
107
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
6
0.010
Why?
Diastole
1
2003
66
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Bradycardia
1
2003
38
0.010
Why?
Systole
1
2003
71
0.010
Why?
Reference Values
1
2003
311
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
191
0.010
Why?
Patient Compliance
1
2003
232
0.010
Why?
Heart Rate
1
2003
313
0.010
Why?
Body Weight
1
2003
524
0.010
Why?
Enzyme Inhibitors
1
2003
371
0.010
Why?
Body Mass Index
1
2003
717
0.010
Why?
Cells, Cultured
1
2003
1569
0.010
Why?
Treatment Outcome
1
2003
5597
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description